ArticleMolecular therapy. Nucleic acids2020

CRISPR-Cas12a Possesses Unconventional DNase Activity that Can Be Inactivated by Synthetic Oligonucleotides.

Bin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.